Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of Early Research on Ivermectin

FLCCC Alliance and British Ivermectin Recommendation Development Group
Jul 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now known with p < 0.00000000001 from 100 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19ivm.org
News release noting that ivermectin remains effective after excluding Elgazzar et al. Given the large magnitude effects and 61 studies, excluding one study with ~3% of patients does not significantly change the evidence base.
FLCCC et al., 16 Jul 2021, preprint, 2 authors.
This PaperIvermectinAll
Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of Early Research on Ivermectin
A reexamination of the data without the earlier research continues to prove that ivermectin is effective in preventing and treating COVID-19 WASHINGTON, D.C. and BATH, SOMERSET, U.K. -The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, and the British Ivermectin Recommendation Development Group (BIRD), a U.K. based group of medical and scientific experts from over 15 countries, are concerned over the misrepresentation of science in the recent article published in the Guardian regarding the withdrawal of Professor Emeritus Ahmed Elgazzar!s study into ivermectin that was first posted December 16, 2020. Contrary to the voices quoted in the article, there is no scientific basis to state that the removal of one study from meta-analyses would "reverse results.!#Worryingly, this article!s insinuation is reported as if it is fact. According to the most recent analyses by BIRD, excluding the Elgazzar data from the cited metaanalyses by Bryant and Hill does not change the conclusions of these reviews, with the findings still clearly favouring ivermectin for both prevention and treatment. This article raise questions of journalistic integrity and we invite the Guardian to make appropriate corrections to the reporting and properly check the veracity of their claims. $This is not just about correcting facts but about people!s lives," said Dr. Tess Lawrie, director of the Evidence-Based Medicine Consultancy and organizer of the BIRD group. $Ivermectin is already in use around the world and can reach the poorest people long before other expensive COVID treatments will ever get to them. Ivermectin has an ever-increasing evidence base that shows that it works -even the prestigious Institute Pasteur in France has confirmed that the evidence is sound." $When we examine the extensive evidence on ivermectin as a treatment for COVID-19 without this latest study, we still see a significant reduction in the spread of COVID-19 as well as a reduction in hospitalizations and death," said Dr. Pierre Kory, president and chief medical officer of the FLCCC. $All science needs to be scrutinized. As some of the most published researchers in our fields, we are used to having our work examined by others. I hope that Dr. Elgazzar!s work will be impartially judged and any errors that might be found are corrected.
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit